Aspirin for primary prevention                             Risk of major bleeding from aspirin                                                   Use with caution in                      Moderate                Strong                                  a 
of cardiovascular disease                                  increases markedly in older age. Several                                             adults ≥70 years                                                                                          n 
and colorectal cancer                                      studies suggest lack of net beneﬁt when                                                                                                                                                        i 
                                                           used for primary prevention in older adult                                                                                                                                                     y. 
                                                           with cardiovascular risk factors, but evidence                                                                                                                                                 e 
                                                           is not conclusive. Aspirin is generally                                                                                                                                                        m 
                                                           indicated for secondary prevention in older                                                                                                                                                    / 
                                                           adults with established cardiovascular 
                                                           disease. 
Dabigatran                                                 Increased risk of gastrointestinal bleeding                                           Use with caution                         Moderate                Strong                                   7 
Rivaroxaban                                                compared with warfarin and reported rates                                            for treatment of                                                                                          b 
                                                           with other direct oral anticoagulants when                                           VTE or atrial                                                                                             t 
                                                           used for long-term treatment of VTE or atrial                                        ﬁbrillation in adults                                                                                     l  
                                                           ﬁbrillation in adults ≥75 years.                                                     ≥75 years                                                                                                 v 
Prasugrel                                                  Increased risk of bleeding in older adults;                                           Use with caution in                      Moderate                Weak                                    y 
                                                           beneﬁt in highest-risk older adults (eg, those                                       adults ≥75 years                                                                                          I 
                                                           with prior myocardial infarction or diabetes                                                                                                                                                   n 
                                                           mellitus) may offset risk when used for its                                                                                                                                                    a 
                                                           approved indication of acute coronary                                                                                                                                                          t 
                                                           syndrome to be managed with percutaneous                                                                                                                                                       W 
                                                           coronary intervention.                                                                                                                                                                         O 
Antipsychotics                                             May exacerbate or cause SIADH or                                                      Use with caution                         Moderate                Strong                                  e 
Carbamazepine                                              hyponatremia; monitor sodium level closely                                                                                                                                                     r 
Diuretics                                                  when starting or changing dosages in older                                                                                                                                                     o 
Mirtazapine                                                adults                                                                                                                                                                                          3 
Oxcarbazepine                                                                                                                                                                                                                                              2 
SNRIs 
SSRIs                                                                                                                                                                                                                                                       
TCAs                                                                                                                                                                                                                                                      T 
Tramadol 
Dextromethorphan/                                          Limited efﬁcacy in patients with behavioral                                           Use with caution                         Moderate                Strong                                  C 
quinidine                                                  symptoms of dementia (does not apply to                                                                                                                                                        i 
                                                           treatment of PBA). May increase risk of falls                                                                                                                                                  s  
                                                           and concerns with clinically signiﬁcant drug                                                                                                                                                   p 
                                                           interactions. Does not apply to treatment of                                                                                                                                                   n 
                                                           pseudobulbar affect.                                                                                                                                                                           i 
Trimethoprim-                                              Increased risk of hyperkalemia when used                                              Use with caution in                      Low                     Strong                                  y. 
sulfamethoxazole                                           concurrently with an ACEI or ARB in                                                   patients on ACEI                                                                                         e 
                                                           presence of decreased creatinine clearance                                           or ARB and                                                                                                m 
                                                                                                                                                decreased 
                                                                                                                                                creatinine                                                                                                n 
                                                                                                                                                clearance 
